Advertisement

Topics

Global Tinea Pedis Treatment Market 20172021 [Updated: 14062017] Prices from USD $3500

08:15 EDT 19 Jun 2017 | BioPortfolio Report Blog

About Tinea Pedis Treatment
Tinea pedis, also known as athlete's foot, is caused by dermatophyte fungus on foot and can spread to toenails and hands. It is a dermatophyte infection of the soles of the feet and the interdigital spaces. Tinea pedis thrives in warm, humid conditions and is most common among young adult men. Tinea pedis can be transmitted through direct contact with an infected person or by touching surfaces contaminated with the fungus. This fungus lives in warm, moist environments and is found in showers, locker room floors, and swimming pools.

Technavio's analysts forecast the global tinea pedis treatment market to grow at a CAGR of 3.03% during the period 20172021.

Covered in this report
The report covers the present scenario and the growth prospects of the global tinea pedis treatment market for 20172021. To calculate the market size, the report considers the sales of both branded and generic drugs sales.

The market is divided into the following segments based on geography:
Americas
APAC
EMEA

Technavio's report, Global Tinea Pedis Treatment Market 20172021, has been prepared based on an indepth market analysis with inputs from industry experts. The report covers the market landscape and its growth prospects over the coming years. The report also includes a discussion of the key vendors operating in this market.

Key vendors
GSK
Exeltis USA
Valeant
Viamet Pharmaceuticals

Other prominent vendors
Allergan
Almirall
Amgen
Aqua Pharmaceuticals
AstraZeneca
Bayer
BristolMyers Squibb
Celgene
Dermira
Elorac
F. HoffmannLa Roche
Galderma
Genentech
Hexima
Hisamitsu Pharmaceutical
Incyte
Mayne Pharma
MediQuest Therapeutics
Meiji Seika Pharma
Merz Pharmaceuticals
Moberg Pharma
Mylan Pharmaceuticals
NanoBio
NovaBiotics
Novan
Nuvo Research
Polichem
Promius Pharma
Sanofi
Seren Pharmaceuticals
Sun Pharma
Taro
Teva Pharmaceutical
Theravance Biopharma
Tinea Pharmaceuticals
Market driver
High unmet needs
For a full, detailed list, view our report

Market challenge
Increased availability of generics and alternative therapies
For a full, detailed list, view our report

Market trend
Increased funding for antifungal research
For a full, detailed list, view our report

Key questions answered in this report
What will the market size be in 2021 and what will the growth rate be?
What are the key market trends?
What is driving this market?
What are the challenges to market growth?
Who are the key vendors in this market space?
What are the market opportunities and threats faced by the key vendors?
What are the strengths and weaknesses of the key vendors?

You can request one free hour of our analyst's time when you purchase this market report. Details are provided within the report.

Original Article: Global Tinea Pedis Treatment Market 20172021 [Updated: 14062017] Prices from USD $3500

NEXT ARTICLE

More From BioPortfolio on "Global Tinea Pedis Treatment Market 20172021 [Updated: 14062017] Prices from USD $3500"

Advertisement
Quick Search
Advertisement
Advertisement

 

Relevant Topics

Infectious-diseases
Antiretroviral Therapy Clostridium Difficile Ebola HIV & AIDS Infectious Diseases Influenza Malaria Measles Sepsis Swine Flu Tropical Medicine Tuberculosis Infectious diseases are caused by pathogenic...

The Top 100 Pharmaceutical Companies
Top 10 biotech and pharmaceutical companies worldwide based on market value in 2015 2015 ranking of the global top 10 biotech and pharmaceutical companies based on revenue (in billion U.S. dollars) Johnson & Johnson, U.S. 74...

Generics Drugs
A generic drug (generic drugs, short: generics) is a drug defined as "a drug product that is comparable to brand/reference listed drug product in dosage form, strength, route of administration, quality and performance characteristics, and intended u...